FeaturedNeurologyNeuroscience·May 10, 2019·6 min readStatins’ potential to treat MS unrelated to lowering cholesterolThe common statin drug Simvastatin reduces brain atrophy and slows the progression of secondary progressive multiple sclerosis (SPMS). The effects appear to be independent of the drug's cholesterol-lowering effects.Read More
FeaturedNeurology·February 8, 2017·3 min readShedding Light on the Biology of Progressive Form of Multiple SclerosisNew research could help develop treatments for secondary progressive multiple sclerosis.Read More
